CN106606508A - Available microcrystalline cellulose for preventing and treating cervical cancer - Google Patents

Available microcrystalline cellulose for preventing and treating cervical cancer Download PDF

Info

Publication number
CN106606508A
CN106606508A CN201510719546.7A CN201510719546A CN106606508A CN 106606508 A CN106606508 A CN 106606508A CN 201510719546 A CN201510719546 A CN 201510719546A CN 106606508 A CN106606508 A CN 106606508A
Authority
CN
China
Prior art keywords
microcrystalline cellulose
cancers
cancer
viruses
bacteria
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201510719546.7A
Other languages
Chinese (zh)
Inventor
余秀民
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201510719546.7A priority Critical patent/CN106606508A/en
Publication of CN106606508A publication Critical patent/CN106606508A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716Glucans
    • A61K31/717Celluloses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The cervical cancer is an evil consequence under the synergistic effect generated by lots of small molecular compounds secreted by viruses mainly including HPV (human papillomaviruses), various bacteria, mycoplasmas, trichomonad and the like. The microcrystalline cellulose has an extremely strong adsorption effect for the viruses, the bacteria and various products secreted by the viruses and the bacteria. In addition, the microcrystalline cellulose can adsorb cancer cells and normal cells, prevent metastasis and diffusion of the cancer cells, and protect the normal cells. Therefore, it is proposed that for the cancers of certain organs, such as breast cancers, cervical cancers, skin cancers, penile cancers and the like, if the body is not sutured and opened after the cancer cells are resected in the operation, ''chemotherapy'' and ''radiotherapy'' do not need to be applied, and ''microwave therapy'' can try to be applied. The microcrystalline cellulose is a standing auxiliary material, is cheap and easy to obtain, is free from bad reactions and absolutely safe, and therefore can be safely applied.

Description

Preventing and treating cervical carcinoma can use microcrystalline cellulose
Technical field
Female malignant, first is breast cancer, and second is cervical carcinoma.Up to 320,000 people, this life and health to women threatens very big, causes the great attention of people in the death toll whole world of annual cervical carcinoma.
Background technology
The definite cause of disease of cervical carcinoma or chief culprit, are exactly HPV viral, are people's mamillary cancer virus.This virus has 100 polytypes, wherein there is kind more than 30 to infect genital area, can cause genital wart, causes cell precancerous lesion occur, and some types in people's mamillary cancer virus are relevant with the neoplasmata genitalis of women cervical carcinoma and the common patient of other men and women.
The coating appearance of HPV viruses, also length have a furcella, some furcella tubbiness and sharp.In sexual intercourse, strongly, the telotism on the bridegroom's or husband's side becomes thick to both sides' heat, makes sheath expansion thinning, adds the climax of women, and during the strong contraction of uterus, virus is possible to puncture mantle and run away to uterine cavity the inside and propagate infect.Documents and materials (Guangzhou Daily) are pointed out, and HPV venereal infections are generally easy to very much, but it is usually transient to infect, and Jing for a period of time can Lock-out.The author thinks that this Subclinical papillomavirus infection (HPV) does not disappear.Because it is extremely strong that overall virus also includes that furcella body surface is particularly endocorvix affinity to endometrium, almost can be with indissoluble, therefore virus is in cervical tissue cell, secretly to carry out damaging cervical tissue cellular gene activity, manufacture high-risk HPV.In addition, the other factors such as pathogen such as herpes simplex virus II, bacterium staphylococcus, Escherichia coli, streptococcus, cholera bacteria, diplococcus and trachoma mycoplasma and trichomonad, though they can not cause cancer, but they will secrete various small-molecule substances, during cervical carcinoma is formed cooperative effect is produced.
Also a kind of virus, we must enhance your vigilance to it, that is, HIV (human immune deficiency virus), decline can human immunity systemic-function, lose the resistance of disease-resistant anticancer.This viral whole world has 40,000,000 women to account for 48%, becomes the carrier of this kind of virus.
The content of the invention
The above, it is clear that ground is found out, the generation of cervix cancer, be virus headed by HPV and bacterium that some cause genitals inflammation and mycoplasma and trichomonad etc. pathogen mutual synergy caused by malignant tumour (cervix cancer).
In the case of available without antiviral drugs, we have pushed away microcrystalline cellulose out.Microcrystalline cellulose is a kind of polar adsorbent, not only can adsorb also can absorb virus (because it has porous), and can adsorb bacterium (negatively charged in body cavity mucosa) and its secreted various micromolecular compounds, it is most likely that unexpected clinical efficacy can be received.
The also adsorbable leucocyte of microcrystalline cellulose, and can especially adsorb cancer cell.This makes microcrystalline cellulose have another kind of anti-cancer properties, and cancer cell can be prevented to invade normal cell, that is, protects normal cell, not by cancer cells challenge, prevents the transfer diffusion of cancer cell.Because the accumulation mutation that cancer cell is damaged gene forms the different cell of structural component, microcrystalline cellulose adsorbs more powerful to it.
Specific embodiment
Embodiment 1, using formulation
Make soft modeling ampulla, nozzle proper extension fills 5 grams and 3 grams/, ampoule, fix tentatively dry powder spray administration every night, morning or morning hydro-peening, spray scouring water can with nothing from sterilized water be market betray 10,000 milliliters it is bottled.
Embodiment 2, usage and dosage, packaged ampulla propellant can also be with half, it is also possible to 2, if patient's detection love is hereby viral, takes this opportunity, and can increase times for spraying, so as to viral adsorption, extends the life-span.It is a kind of newest method with " micro- therapy " treatment " love is hereby sick ", special item might as well be carried out.The histocyte of all organs, its after birth is all lipid bilayer, and love is hereby viral, and what is had is soluble in the after birth of lipid bilayer in blood, and then departs from blood and escape from outside blood vessel.But there is being exposed at outside blood vessel for big half body, half body and little half body certainly, microcrystalline cellulose can all suck out removing them in " micro- treatment ".I think, there is a mucous membrane in oral cavity, gum periodontal soft tissue, sublingual thin vessels at most, oral cavity also the normal bleedings of Jing, bleed, oozing of blood, therefore implement that " micro- treatment " is most effective in cure in oral cavity, through " micro- treatment " of one section of long period, certainly patient can take a favorable turn.

Claims (3)

1. it is most effective most rational selection to prevent and treat cervix cancer with microcrystalline cellulose, be it is characterized in that:Microcrystalline cellulose can most adsorb the polar adsorbent for absorbing HPV viruses.
2. it is most effective most rational selection to prevent and treat cervix cancer with microcrystalline cellulose, be it is characterized in that:Microcrystalline cellulose has the suction-operated of strength to charged pathogen, can also absorb various bacteriums and the product secreted by pathogen.
3., according to the narration of (1) and (2), (3) are characterized in that:Microcrystalline cellulose energy strong adsorption cancer cell, prevents cancer metastasis and diffusion, protects normal cell.
CN201510719546.7A 2015-10-27 2015-10-27 Available microcrystalline cellulose for preventing and treating cervical cancer Pending CN106606508A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510719546.7A CN106606508A (en) 2015-10-27 2015-10-27 Available microcrystalline cellulose for preventing and treating cervical cancer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510719546.7A CN106606508A (en) 2015-10-27 2015-10-27 Available microcrystalline cellulose for preventing and treating cervical cancer

Publications (1)

Publication Number Publication Date
CN106606508A true CN106606508A (en) 2017-05-03

Family

ID=58615151

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201510719546.7A Pending CN106606508A (en) 2015-10-27 2015-10-27 Available microcrystalline cellulose for preventing and treating cervical cancer

Country Status (1)

Country Link
CN (1) CN106606508A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108300713A (en) * 2017-12-31 2018-07-20 宁波大学 The method and device of fixed cell

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108300713A (en) * 2017-12-31 2018-07-20 宁波大学 The method and device of fixed cell

Similar Documents

Publication Publication Date Title
CN102755426B (en) Chinese medicament for treating gynecological inflammation and preparation method
CN106466454A (en) A kind of prevention and the gel for the treatment of gynecological inflammation
CN103070963B (en) Traditional Chinese medicine preparation for treating candida albicans infection diseases
CN102688383B (en) Traditional Chinese medicine composite for treating body surface ulcer or fester
WO2011023013A1 (en) Medicine for dissolving and eliminating wart and excrescence consisting of protein and its uses
CN102335309B (en) Formula of ointment for treating burns and scalds
CN108619362A (en) A kind of acne cream and preparation method thereof
CN102274305B (en) Detoxifying ointment prepared from Chinese herbal medicines
CN101199754B (en) Medicament for treating trauma bleeding, body surface and part cavity film inflammation and preparing method thereof
CN102872246B (en) Medicine for treating cervical erosion through HPV (human papillomavirus) positive-to-negative change
CN106606508A (en) Available microcrystalline cellulose for preventing and treating cervical cancer
CN108186718A (en) A kind of gynaecology's spray prevented and inhibit HPV viruse
CN103520262B (en) A kind of lipid soluble gynecological gel
CN108310266B (en) Traditional Chinese medicine for treating viral warts
CN104623457B (en) Vagina-shrinking expellent nti-freckle gelling agent and preparation method thereof
CN104623432A (en) Traditional Chinese medicine composition for performing elimination treatment on tumor
CN1274331C (en) Mixture for treating acute condyloma
CN103505525A (en) Medicament for treating haemorrhoids and preparation method thereof
CN100534463C (en) Ointment for removing toxin
CN102579654A (en) Anti-bacteria medicine for protecting and cleaning human body vagina and preparation method thereof
CN107753577A (en) Chinese medicine controls the formula of hemorrhoid
CN106138124A (en) The new purposes method of Flos abelmoschi manihot total flavones treatment gynaecopathia (vaginitis, cervicitis, cervical erosion)
CN101332276B (en) Traditional Chinese medicine for treating uterus tumour
CN102861149A (en) Liquid medicine for treating haemorrhoids
CN104740528B (en) A kind of traditional Chinese medicine powder for treating cervicitis

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
DD01 Delivery of document by public notice

Addressee: Yu Xiumin

Document name: Notification of Publication of the Application for Invention

DD01 Delivery of document by public notice
DD01 Delivery of document by public notice

Addressee: Yu Xiumin

Document name: Notification of before Expiration of Request of Examination as to Substance

DD01 Delivery of document by public notice
DD01 Delivery of document by public notice

Addressee: Yu Xiumin

Document name: Notification that Application Deemed to be Withdrawn

DD01 Delivery of document by public notice
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20170503

WD01 Invention patent application deemed withdrawn after publication